Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-007845-29Phase 3Completed
Phase 3, randomised, double-blind trial of pitolisant in narcolepsy and cataplexy (2 arms), sponsored by Bioprojet. Primary endpoint: Change from baseline in weekly cataplexy attacks. Started Feb 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-007845-29.